Joelf Posted June 14, 2020 Share Posted June 14, 2020 Baseline use of hydroxychloroquine (HCQ) in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. These efficacy data establish that patients with lupus on baseline therapy with HCQ are not universally protected from COVID-19. BMJ Journals, Ann rheumatologist Dis, 05/07/2020. (Also see Treatments for Lupus) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles. Quote Link to post Share on other sites
Margaret Posted June 15, 2020 Share Posted June 15, 2020 Morning - very useful information as Gareth has been on Plaquenil for 13 years. I was silently hoping it would offer some protection as he also has immune deficiencies, too. Stay safe and healthy, everyone. Margaret Mom to Gareth, 32 years old, DS/ASD Quote Link to post Share on other sites
Joelf Posted June 15, 2020 Author Share Posted June 15, 2020 Thanks, Margaret. I do hope you and the family are keeping well. Best wishes, Quote Link to post Share on other sites
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.